Senior Director, Analytics
Trio Health
Louisville, Colorado, United States
Disclosure(s): Trio Health: Employee
505 - Real-World Use of Cabotegravir Long-Acting for Pre-Exposure Prophylaxis: Data from Trio Health Cohort
Saturday, October 19, 2024
10:45 AM – 11:00 AM US PT